ArticleJournal of pharmacy & bioallied sciences2025
Ceruloplasmin as a Vital Tool for Grading of Preeclampsia: A Case-Control Study in Central India.
Article in Journal of pharmacy & bioallied sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Preeclampsia (PE) is a hypertensive disorder of pregnancy, characterized by high blood pressure (≥ 140/90 mmHg), proteinuria, and edema after 20 weeks of gestation. Affecting 3-10% of pregnancies globally, PE is a leading cause of maternal and fetal morbidity and mortality. Materials and Methods: This case-control study involved 105 pregnant women in their third trimester (28-40 weeks), divided into three groups: 35 normotensive controls, 35 with mild preeclampsia, and 35 with severe preeclampsia. Serum ceruloplasmin levels were measured using a turbidimetry method on a Biosystem BA400 analyzer. Statistical analysis was performed using SPSS software, with Results: The study found significantly higher ceruloplasmin levels in preeclamptic women compared to the control group. Normotensive women had mean ceruloplasmin levels of 84.53 ± 7.33 mg/dl, while women with mild and severe preeclampsia had levels of 107.44 ± 7.37 mg/dl and 135.42 ± 10.73 mg/dl, respectively. The differences were statistically significant ( Conclusion: Elevated serum ceruloplasmin levels were strongly associated with the severity of preeclampsia. Early detection of elevated levels may help in diagnosing and managing preeclampsia, potentially reducing maternal and fetal complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.